home > research channels > sectors > pharma


Latest News
15-Feb-2017 Sun Pharma Feels US Slowdown Pinch, Profit Declines 5%
17-Jan-2017 Daiichi Moves Delhi HC to Block Fortis Stake Sale
27-Dec-2016 Regulator Urged to Stop Monopoly Licensing of New HIV Drug
14-Dec-2016 US FDA Finds Fault with Sun's Testing Programmes at Halol
  more...
Latest Reports
Feb-17 Biosimilar Opportunity For Indian Players
Feb-17 Speeding up FDA approvals, negative for generics; positive for CRAMS
Jan-17 Have USFDA inspections on Indian facilities peaked out?
Jan-17 Truth vs Hype
  more...

Quarterly Summary (December Quarter)
Desc Current Previous Per.Chg
Sales 25088.2 23950.5 4.8
Otherincome 768.9 472.9 62.6
Expense 19524.7 19000.8 2.8
RawMaterial 7310.1 7664.3 -4.6
StaffCost 3609.2 3252.3 11.0
ExciseDuty 144.2 48.8 195.7
OtherExp 6636.3 6178.4 7.4
Interest 421.1 403.6 4.3
GrossProfit 6506.8 5780.7 12.6
Depreciation 1075.3 1000.9 7.4
Tax 1310.3 1038.4 26.2
NetProfit 4056.4 3692.7 9.8
Total.Comp 79 -- --
Source: ETIG Database

Sectoral Companies As on 20 Feb 2017
Company Name (Top 10) MarketCap (Rs.Crore)
Sun Pharma. 163566.13
Lupin 65998.01
Dr.Reddy's 48126.75
Cipla 47776.29
Cadila Healt 45498.35
Aurobindo Ph 39182.07
Piramal Entp 32642.15
Glenmark Pha 26619.93
Alkem Labora 24378.04
GlaxoSmith.P 22709.34
Biocon 22498.00
Torrent Phar 21818.38
Divi's Lab 20093.24
  click here for the complete list